| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,539,000 | 2,065,000 | 2,520,000 | 2,481,400 | | Cost of Revenue | 2,673,000 | 1,253,000 | 2,219,000 | 1,946,900 | | | Gross Profit | (134,000) | 812,000 | 301,000 | 534,500 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (372,000) | 590,000 | 64,000 | 303,200 | | Non Recurring | (142,000) |
-
| (14,000) | 1,400 | | Others | 103,000 | 95,000 | 96,000 | 74,100 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 277,000 | 127,000 | 155,000 | 155,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 | 7,000 | 4,000 | 7,300 | | Earnings Before Interest And Taxes | 282,000 | 134,000 | 159,000 | 161,800 | | Interest Expense | 93,000 | 96,000 | 90,000 | 87,600 | | Income Before Tax | 189,000 | 38,000 | 69,000 | 74,200 | | Income Tax Expense | 65,000 | 13,000 | 24,000 | 7,200 | | Minority Interest |
-
|
-
|
-
| 200 | | | | Net Income From Continuing Ops | 124,000 | 25,000 | 45,000 | 67,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 124,000 | 25,000 | 45,000 | 67,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $124,000 | $25,000 | $45,000 | $67,000 |
|
0.51% Nasdaq 
Income Statement
